Lai YH, Koo S, Oh SW, Driskell EA, Driskell JD. Rapid screening of antibody-antigen binding using dynamic light scattering (DLS) and gold nanoparticles. Anal Method 2015, 7, 7249-7255.

Driskell JD, Jones CA, Tompkins SM, Tripp RA. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. Analyst 2011, 136, 3083-3090.

Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou J, Chen H, Huo Q. A One-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc. 2008, 130, 2780-2782.

D2Dx™ - A Single-Step and Washing-Free Immunoassay Technology

FEATURED ARTICLES

EXHIBITIONS, NEWS & HIGHLIGHTS

Nano Discovery Inc. is a proud winner of 2015 TechConnect National Innovation Summit, Washington, D.C.

Nano Discovery Inc. will exhibit at the 32nd Clinical Virology Symposium 2016, May 19-22, Daytona, Florida (Booth 429)

D2Dx-R Assay Reader

Compact device to read assay results

Gold Immunoprobes

AuNP-antibody conjugations kits

MRI Global Diagnostics (Palm Bay, FL) will present a work on "Rapid Detection of Influenza A Virus via a Single-Step Immunoassay Technology " (the D2Dx™ technology) at the 32nd Clinical Virology Symposium 2016, May 19-22, Daytona, Florida

D2Dx™ (from diameter to diagnostics) detects target analytes by measuring the average diameter change of gold nanoparticle (AuNP) immunoprobes upon binding with the target analytes. To conduct the assay, gold nanoparticles conjugated to specific antibodies (the AuNP immunoprobes) are simply mixed with sample solutions. Following an incubation period of 5-30 min, the binding of the target analytes with the gold nanoparticle immunoprobes can lead to nanoparticle cluster or aggregate formation. The average particle size increase of the assay solution is measured using D2Dx-R assay reader and is correlated to the target analyte concentration.